22 May 2025

Cancer Pharmaceuticals TGA

‘Important step forward’ in endometrial cancer treatment

24 April 2025

Paediatric oncology TGA

TGA tick for brain cancer drug

10 April 2025

Breast cancer TGA

Ribociclib welcomed in by TGA

27 March 2025

Technology TGA

TGA and international partners prioritise joint product reviews

27 February 2025

Pharmaceuticals TGA

TGA gives tislelizumab the thumbs up

22 August 2024

Allergies FDA TGA

Needle-free adrenaline wins FDA green light

22 August 2024

cardiovascular

Rare CV deaths warning on azithromycin

27 June 2024

Clinical Respiratory Shortages TGA

Two more liquid antibiotics join the shortage list

27 June 2024

AMA TGA

Unapproved meds should be flagged to TGA: AMA

6 September 2023

TGA TheHill

TGA’s plan to tackle drug shortage

12 July 2023

TGA

Peak health bodies unite to fight drug discontinuation

17 May 2023

Drugs TGA

The legacy of John Skerritt

19 April 2023

TGA

Dual drug labelling on the way out

24 August 2022

COVID-19 TGA

TGA paves the way for third covid antiviral

23 March 2022

Breast cancer Clinical research TGA

“Impressive” results in breast cancer drug trial

23 March 2022

Clinical Drugs Medicolegal Political Public Health TGA

Drug approvals ‘rushed, based on limited data’

9 March 2022

COVID-19 prevention therapy TGA

Access concerns for ‘game-changing’ covid therapy

23 February 2022

COVID-19 TGA

Covid treatments for the immune compromised

16 June 2021

PBS TheHill

New cancer drug approvals

22 April 2021

Clinical Lung cancer TGA

Durvalumab indications extended by TGA